UTHR - United Therapeutics Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue1,627,8001,725,3001,598,8001,465,800
Cost of Revenue198,700105,70072,70069,000
Gross Profit1,429,1001,619,6001,526,1001,396,800
Operating Expenses
Research Development357,900264,600147,600245,100
Selling General and Administrative263,300332,600319,300452,700
Non Recurring----
Others----
Total Operating Expenses819,900702,900539,600766,800
Operating Income or Loss807,9001,022,4001,059,200699,000
Income from Continuing Operations
Total Other Income/Expenses Net-49,000-252,9001,000345,400
Earnings Before Interest and Taxes807,9001,022,4001,059,200699,000
Interest Expense-13,900-9,000-3,900-4,700
Income Before Tax758,900769,5001,060,2001,044,400
Income Tax Expense169,700351,600346,500392,800
Minority Interest----
Net Income From Continuing Ops589,200417,900713,700651,600
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income589,200417,900713,700651,600
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares589,200417,900713,700651,600